• Je něco špatně v tomto záznamu ?

Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats

Bubeníková-Valesová V, Balcar VJ, Tejkalová H, Langmeier M, St'astný F.

. 2006 ; 48 (6-7) : 515-522.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07521895

N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.

000      
00000naa 2200000 a 4500
001      
bmc07521895
003      
CZ-PrNML
005      
20111210133022.0
008      
090422s2006 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Valešová, Věra, $d 1977- $7 nlk20050173200
245    10
$a Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats / $c Bubeníková-Valesová V, Balcar VJ, Tejkalová H, Langmeier M, St'astný F.
314    __
$a Prague Psychiatric Centre Affiliated with Third Faculty of Medicine & Centre of Neuropsychiatric Studies, 181 03 Prague 8, Czech Republic
520    9_
$a N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a fragmentace DNA $7 D053938
650    _2
$a dipeptidy $x aplikace a dávkování $x fyziologie $7 D004151
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hipokampus $x patologie $x růst a vývoj $x účinky léků $7 D006624
650    _2
$a koncové značení zlomů DNA in situ $7 D020287
650    _2
$a injekce intraventrikulární $7 D007276
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a neurodegenerativní nemoci $x chemicky indukované $x patofyziologie $x patologie $7 D019636
650    _2
$a neurony $x patologie $x účinky léků $7 D009474
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a financování organizované $7 D005381
700    1_
$a Balcar, V. J.
700    1_
$a Tejkalová, Hana, $d 1948- $7 xx0070846
700    1_
$a Langmeier, Miloš, $d 1951- $7 jn20000710407
700    1_
$a Šťastný, František, $d 1942- $7 xx0002050
773    0_
$w MED00003485 $t Neurochemistry international $g Roč. 48, č. 6-7 (2006), s. 515-522 $x 0197-0186
910    __
$a ABA008 $b x $y 9
990    __
$a 20090312170439 $b ABA008
991    __
$a 20090717114512 $b ABA008
999    __
$a ok $b bmc $g 644984 $s 497900
BAS    __
$a 3
BMC    __
$a 2006 $b 48 $c 6-7 $d 515-522 $i 0197-0186 $m Neurochemistry international $x MED00003485
LZP    __
$a 2009-B1/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...